Position in ELDN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,795,531
+$5,412,223 QoQ
Shares Held
6,293,282
0.0% QoQ
Ownership
7.74%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#1
of 159 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ELDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BVF INC/IL holds $3,440,293,274 across 41 Biotechnology names. ELDN ranks #28 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,965,160 | $555,315,164 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
3,872,052 | $444,008,202 | |
| 3 | MLTX |
MoonLake Immunotherapeutics
|
16,001,284 | $311,544,999 | |
| 4 | GHRS |
GH Research PLC
|
8,650,158 | $232,516,247 | |
| 5 | GPCR |
Structure Therapeutics Inc.
|
3,366,823 | $180,697,390 | |
| 6 | NKTR |
Nektar Therapeutics
|
2,391,075 | $166,920,945 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,056,027 | $123,629,080 | |
| 8 | XNCR |
Xencor Inc
|
7,133,720 | $114,852,892 |
All Filings in ELDN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,795,531 | 6,293,282 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $19,383,308 | 6,293,282 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,502,855 | 6,293,282 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $16,299,600 | 6,293,282 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $17,054,794 | 6,293,282 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $21,334,225 | 6,293,282 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $25,928,321 | 6,293,282 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $15,670,272 | 6,293,282 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $16,614,264 | 6,293,282 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,913,022 | 4,326,710 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,788,078 | 4,326,710 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,927,592 | 4,326,710 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,927,592 | 4,326,710 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,491,035 | 2,326,710 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,304,898 | 2,326,710 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,421,719 | 2,326,710 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,677,172 | 2,326,710 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $9,167,237 | 2,326,710 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,077,068 | 1,378,020 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,426,028 | 1,363,435 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,807,270 | 1,113,435 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $11,913,754 | 1,113,435 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||